Canada Is Building a 200-Substance Evidence Queue

Canada has opened a two-stage information program covering 200 chemical substances. Notices published in the Canada Gazette on 29 August 2026 use section 71 of the Canadian Environmental Protection Act to require specified manufacturers, importers and users to provide commercial, facility, release and use information.

Phase 1 covers 184 substances and is open now, with responses due by 3 March 2027. Phase 2 covers 16 substances and runs from 4 March to 8 September 2027. An organization subject to both notices must submit separately for each phase.

The notices do not declare all 200 substances toxic. They create an evidence queue. Environment and Climate Change Canada and Health Canada will use the returns to understand where priority substances are made, imported or used, in what quantities, in which products and facilities, and with what releases. Those facts can support assessment and decisions about whether and how a substance should be controlled.

Thresholds define the visible market

Reporting obligations vary by the part of the schedule and the commercial activity. The guidance uses quantity thresholds of more than 100 kilograms or more than 1,000 kilograms. For relevant imports and uses in mixtures, products or manufactured items, a concentration threshold of at least 0.1 per cent also applies.

These thresholds are not clerical details. They define which parts of the market become visible through mandatory reporting. A large volume of a low-concentration substance may fall outside a criterion, while a smaller product stream at a higher concentration may be captured. The rules apply by substance and activity across the company, so fragmented purchasing or importing records still have to be assembled into one answer.

The guidance encourages organizations below mandatory thresholds, or those holding other useful information, to submit a Declaration of Stakeholder Interest. That creates a voluntary layer around the compulsory dataset. It can reveal activities the thresholds miss, but regulators will need to keep mandatory and voluntary evidence distinguishable when judging coverage.

A chemical inventory is a network problem

Few organizations hold every required fact in one system. Substance identity may sit with product stewardship. Import quantities may sit with customs teams. Mixture concentrations may be in supplier documentation. Facility releases may be held by environmental managers, and end uses by sales or manufacturing units.

The reporting exercise therefore tests how well a company can connect records across its own organization and supply chain. A trade name is not enough if it cannot be mapped to a reportable substance identity. A purchase total is not enough if concentration is unknown. A supplier statement is not enough if the company cannot show how it used the information to calculate the report.

Section 71 reaches information in a person’s possession or information to which that person may reasonably be expected to have access. That standard makes data governance part of environmental compliance. Companies cannot assume that a record held by an employee, agent or accessible supplier system is irrelevant because it was not created by the environmental team.

Collection is the beginning of the regulatory task

Canada has provided flowcharts, examples, an Excel reporting file and a Single Window submission route. Those tools can reduce inconsistent interpretation. They do not resolve the analytical work after submissions arrive.

The two-phase design should help regulators manage volume, but it also creates a long evidence cycle. Phase 2 does not close until September 2027. The public value of the program will depend on what happens next: validation of returns, identification of coverage gaps, assessment priorities, publication of findings and proportionate control decisions where warranted.

Quality checks should look for mismatched substance identifiers, implausible quantities, unexplained differences between facilities and incomplete release information. Regulators also need a method for dealing with confidential business information without making the resulting assessment impossible for the public to understand.

The best outcome is not the largest spreadsheet. It is a decision record that shows how commercial evidence changed the government’s view of exposure, use or release. Where the data do not support a concern, that conclusion should be visible. Where they reveal a risk or an information gap, the next request or control should be tied to it.

Canada’s notices make industry records an input to public environmental judgment. Their strength lies in breadth, legal authority and defined thresholds. Their weakness will be delay if collection becomes an end in itself. A 200-substance queue is defensible when each substance can move from request to validated evidence and then to a clear disposition.